Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas White

Showing results (81-90 of 89) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 89 results.
Plos Medicine|August 7, 2007
Toll-like receptor 2 impairs host defense in gram-negative sepsis caused by Burkholderia pseudomallei (Melioidosis)W Joost Wiersinga, Catharina W Wieland, Mark C Dessing, et al.
Clinical Pharmacology and Therapeutics|December 20, 2023
A Randomized Phase I Study of the Anti-Interleukin-33 Antibody Tozorakimab in Healthy Adults and Patients With Chronic Obstructive Pulmonary DiseaseFred Reid, Dave Singh, Muna Albayaty, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 10, 2013
Determinants of mortality in a combined cohort of 501 patients with HIV-associated Cryptococcal meningitis: implications for improving outcomesJoseph N Jarvis, Tihana Bicanic, Angela Loyse, et al.
The Journal of Allergy and Clinical Immunology|April 22, 2026
AZD8630/AMG 104, an inhaled Anti-TSLP antibody fragment, for moderate-to-severe asthma: a phase 1 randomized controlled trialSarah R Doffman, Davinder P S Dosanjh, Muhammad Waqas Sadiq, et al.
Scientific Reports|December 5, 2018
Engineering of a GLP-1 analogue peptide/anti-PCSK9 antibody fusion for type 2 diabetes treatmentMatthieu Chodorge, Anthony J Celeste, Joseph Grimsby, et al.
Mabs|April 15, 2026
Preclinical characterization of AZD1163, a first-in-class anti-PAD2/4 bispecific antibody for the treatment of rheumatoid arthritisGary P Sims, Lacie Scaletta, John Andrews, et al.
Wellcome Open Research|February 26, 2019
A randomized open label trial of tamoxifen combined with amphotericin B and fluconazole for cryptococcal meningitisNguyen Thi Thuy Ngan, Nguyen Thi Hoang Mai, Nguyen Le Nhu Tung, et al.
The New England Journal of Medicine|December 14, 2007
Dexamethasone in Vietnamese adolescents and adults with bacterial meningitisThi Hoang Mai Nguyen, Thi Hong Chau Tran, Guy Thwaites, et al.
Nature Communications|November 21, 2025
Microbial aerotrophy enables continuous primary production in diverse cave ecosystemsSean K Bay, Gaofeng Ni, Rachael Lappan, et al.
Pageof 9

Showing results (81-90 of 89) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 89 results.
Plos Medicine|August 7, 2007
Toll-like receptor 2 impairs host defense in gram-negative sepsis caused by Burkholderia pseudomallei (Melioidosis)W Joost Wiersinga, Catharina W Wieland, Mark C Dessing, et al.
Clinical Pharmacology and Therapeutics|December 20, 2023
A Randomized Phase I Study of the Anti-Interleukin-33 Antibody Tozorakimab in Healthy Adults and Patients With Chronic Obstructive Pulmonary DiseaseFred Reid, Dave Singh, Muna Albayaty, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 10, 2013
Determinants of mortality in a combined cohort of 501 patients with HIV-associated Cryptococcal meningitis: implications for improving outcomesJoseph N Jarvis, Tihana Bicanic, Angela Loyse, et al.
The Journal of Allergy and Clinical Immunology|April 22, 2026
AZD8630/AMG 104, an inhaled Anti-TSLP antibody fragment, for moderate-to-severe asthma: a phase 1 randomized controlled trialSarah R Doffman, Davinder P S Dosanjh, Muhammad Waqas Sadiq, et al.
Scientific Reports|December 5, 2018
Engineering of a GLP-1 analogue peptide/anti-PCSK9 antibody fusion for type 2 diabetes treatmentMatthieu Chodorge, Anthony J Celeste, Joseph Grimsby, et al.
Mabs|April 15, 2026
Preclinical characterization of AZD1163, a first-in-class anti-PAD2/4 bispecific antibody for the treatment of rheumatoid arthritisGary P Sims, Lacie Scaletta, John Andrews, et al.
Wellcome Open Research|February 26, 2019
A randomized open label trial of tamoxifen combined with amphotericin B and fluconazole for cryptococcal meningitisNguyen Thi Thuy Ngan, Nguyen Thi Hoang Mai, Nguyen Le Nhu Tung, et al.
The New England Journal of Medicine|December 14, 2007
Dexamethasone in Vietnamese adolescents and adults with bacterial meningitisThi Hoang Mai Nguyen, Thi Hong Chau Tran, Guy Thwaites, et al.
Nature Communications|November 21, 2025
Microbial aerotrophy enables continuous primary production in diverse cave ecosystemsSean K Bay, Gaofeng Ni, Rachael Lappan, et al.
Pageof 9